Tag: embolics
IDE pivotal trial for novel liquid embolic device completes enrolment
Fluidx Medical Technology has announced completion of patient enrolment in the investigational device exemption (IDE) pivotal clinical trial evaluating the GPX embolic device. The...
Instylla announces completion of financing round
Instylla, a company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the closing of a US$30 million financing round.
This financing round...
